Bajaj Allianz Life Nifty 200 Alpha 30 Index Fund NFO Launched for ULIP customers

·        NFO Period till 15th September, 2024

Bajaj Allianz Life Insurance, one of India's leading private life insurers, today announced the launch of its new fund – Bajaj Allianz Life Nifty 200 Alpha 30 Index Fund, which will be available along with its ULIP products. This new fund presents a unique opportunity for investors to capitalize on the growth potential of high-alpha stocks, diversify their portfolios, and enjoy the benefits of an index-based investment approach, along with a life cover. The NFO period for Bajaj Allianz Life Nifty 200 Alpha 30 Index Fund ends on 15th September, 2024.

The Nifty 200 Alpha 30 Index focuses on stocks that generate returns higher than expected, using a measure called Jensen Alpha (α). Simply put, Jensen Alpha represents the extra profit a stock or investment makes compared to the market’s expectations, as calculated using the capital asset pricing model. This fund aims to grow your money by investing in the top 30 stocks from the Nifty 200 Index that have the highest alpha value.

Investors should note that their investments are subject to higher market risk and volatility. Hence, this fund is a good fit for those with a higher risk appetite and a long-term investment horizon.

Speaking on the launch of the new fund, Mr. Tarun Chugh, MD & CEO, Bajaj Allianz Life Insurance, said, “As life goals enablers for India, it’s our commitment to provide customers with reliable tools to achieve their long-term financial goals. With our resilient economy and the strong historical performance of the Indian equity market, the Bajaj Allianz Life Nifty 200 Alpha 30 Index Fund offers an opportunity for our customers to achieve their financial objectives. The historical data of the past five years indicates that a balanced allocation between large and mid-cap stocks, with the Nifty 200 Alpha 30 Index, has been consistently outperforming other market-cap indices across multiple timeframes. Additionally, this fund offers a diversified and passive investment approach with significant growth potential. These features, combined with the advantages of being integrated into a ULIP, are key reasons for customers to review their fund allocation with this launch and get closer to their financial goals.”

The fund aims to replicate the performance of the benchmark index (Nifty 200 Alpha 30 Index), subject to tracking error. The Index will be reconstituted quarterly in March, June, September and December. 

Bajaj Allianz Life ULIP products with underlying Nifty 200 Alpha 30 Index Fund, enables policyholders to achieve their life goals, powered by the security of a life cover and the opportunity for wealth creation.

For more information on the Bajaj Allianz Life Nifty 200 Alpha 30 Index Fund, please visit our website: https://www.bajajallianzlife.com/

  • Related Posts

    Mumbai Students Win Big at Robotics Championship in Chicago, Headed to World Finals

    In an exceptional achievement, Mumbai-based high school robotics team Sigma 9692 has won the prestigious Engineering Inspiration Award at the FIRST Robotics Midwestern Regional Championship held in Chicago, USA. With…

    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    The National Bio Entrepreneurship Competition (NBEC), India’s largest and most prestigious bio-entrepreneurship platform, was officially launched on 3rd April 2025 at Startup Maha Kumbh, marking the opening of applications for…

    You Missed

    Mumbai Students Win Big at Robotics Championship in Chicago, Headed to World Finals

    • By editor
    • April 5, 2025
    • 38 views
    Mumbai Students Win Big at Robotics Championship in Chicago, Headed to World Finals

    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    • By editor
    • April 5, 2025
    • 28 views
    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    Moody’s Ratings Upgrades Muthoot Finance Ratings to ‘Ba1’ with ‘Stable’ Outlook

    • By editor
    • April 4, 2025
    • 36 views
    Moody’s Ratings Upgrades Muthoot Finance Ratings to ‘Ba1’ with ‘Stable’ Outlook

    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    • By editor
    • April 4, 2025
    • 40 views
    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future